Weight Gain: Causes, Health Risks & What You Can Do About It
64%
of UK adults are overweight or obese (NHS Health Survey for England)
80×
higher risk of type 2 diabetes associated with obesity compared to healthy weight
5–10%
body weight loss needed to produce clinically meaningful improvements in metabolic health
Weight gain affects nearly two-thirds of UK adults and is associated with a substantially elevated risk of type 2 diabetes, cardiovascular disease, and multiple cancers. Understanding why weight gain happens — and what can be done about it — is central to making meaningful, sustainable change.
This guide covers the principal causes of weight gain, the associated health risks, effective lifestyle interventions, and when MHRA-approved prescription treatment may be appropriate.
Causes of Weight Gain
Weight gain results from a sustained calorie surplus — consuming more energy than the body expends. However, this simple equation conceals considerable biological complexity. The factors driving calorie intake and energy expenditure are diverse, and for many people, biological and hormonal factors make sustained weight loss extremely difficult without additional support.
Diet & lifestyle
High intake of ultra-processed foods, refined carbohydrates, and added sugars; large portion sizes; and frequent snacking significantly increase caloric consumption beyond energy needs.
Physical inactivity
Sedentary desk-based jobs, long periods of screen time, and reduced incidental activity significantly lower daily energy expenditure, contributing to a calorie surplus even without increased food intake.
Sleep deprivation
Poor sleep disrupts ghrelin (appetite-stimulating) and leptin (satiety-signalling) hormones, increasing hunger and food intake. It also promotes poor food choices and raises cortisol, which drives fat storage.
Stress & mental health
Chronic psychological stress elevates cortisol, which promotes abdominal fat storage and drives comfort eating. Depression and anxiety are bidirectionally associated with excess weight gain.
Medications that can cause weight gain
Several commonly prescribed medications are associated with weight gain as a side effect. These include certain antidepressants (particularly tricyclics and SSRIs), corticosteroids used long-term, antipsychotic medications, and some treatments for type 2 diabetes (including sulfonylureas and insulin). It is important never to stop or change prescribed medication without consulting a GP, even if weight gain is suspected as a side effect.
Hormonal and metabolic conditions
Undiagnosed or undertreated hormonal conditions can make weight management significantly harder. These include:
- Hypothyroidism — an underactive thyroid slows metabolism, making weight gain more likely and weight loss more difficult
- Polycystic ovary syndrome (PCOS) — associated with insulin resistance and a tendency towards weight gain, particularly around the abdomen
- Cushing’s syndrome — excess cortisol production leads to characteristic weight gain, particularly centrally
- Insulin resistance — impairs the body’s ability to regulate blood glucose effectively, promoting fat storage
If weight gain persists despite genuine lifestyle change, a blood test with a GP can rule out underlying hormonal or metabolic contributors.
Genetic factors
Research consistently demonstrates that genetic factors account for 40–70% of BMI variability between individuals. Genetic predisposition does not mean weight cannot be managed — but it does help explain why some people find it significantly more difficult than others and why biological support (including medication, where appropriate) can be a legitimate and evidence-based choice.
Health Risks of Excess Weight
| Condition | Risk associated with excess weight |
|---|---|
| Type 2 diabetes | Up to 80× higher risk — excess fat, particularly visceral fat, impairs insulin sensitivity and glucose regulation |
| Cardiovascular disease | Significantly elevated — obesity raises blood pressure, LDL cholesterol, triglycerides, and systemic inflammation |
| Stroke | Around 2× higher risk in adults with obesity compared to healthy weight |
| Cancer | Linked to 13 cancer types including breast, bowel, kidney, uterine, and oesophageal cancers |
| Obstructive sleep apnoea | Excess fatty tissue around the airway restricts breathing during sleep, disrupting rest and cardiovascular function |
| Osteoarthritis | Excess body weight increases mechanical load on weight-bearing joints, accelerating cartilage breakdown |
| Mental health | Bidirectionally associated with depression and anxiety; stigma and social consequences compound the psychological burden |
| Non-alcoholic fatty liver disease (NAFLD) | Strongly associated — excess weight, particularly visceral fat, causes fat accumulation in the liver |
Even a 5–10% reduction in body weight produces clinically meaningful improvements in blood pressure, blood sugar, cholesterol, and joint pain — and reduces the risk of type 2 diabetes by up to 50% in those at high risk (NICE CG189).
Lifestyle Changes That Work
For many adults, a combination of dietary modification, increased physical activity, improved sleep, and stress management is sufficient to achieve clinically meaningful weight loss. NICE guidance identifies the following as the evidence-based components of effective lifestyle-based weight management:
- Moderate calorie deficit — aim for approximately 500–600 kcal below daily maintenance energy requirements
- Reduce ultra-processed foods — replace with whole foods, lean protein, vegetables, and dietary fibre, which promote satiety and support a healthy gut microbiome
- Regular physical activity — NICE recommends at least 150 minutes of moderate-intensity activity per week; even brisk walking significantly improves metabolic health
- Improve sleep quality — consistent 7–9 hours of sleep supports healthy regulation of ghrelin and leptin, reducing appetite-driven overeating
- Manage stress — mindfulness, structured relaxation, therapy, and regular activity all reduce cortisol-driven eating behaviour
- Behavioural support — NICE consistently identifies behavioural interventions as improving long-term weight loss outcomes compared to dietary advice alone
When Medication Might Help
NICE guidance recommends considering prescription weight loss medication as an adjunct to lifestyle modification — not a replacement for it — for adults who meet clinical eligibility criteria and have been unable to achieve clinically meaningful weight loss through lifestyle changes alone.
Eligibility criteria (NICE CG189 and TA guidelines): a BMI of 30 or above, or a BMI of 27–29.9 with at least one weight-related health condition (such as type 2 diabetes, hypertension, or dyslipidaemia), and evidence of genuine prior lifestyle modification.
Most effective — MHRA approved Nov 2023
Mounjaro (tirzepatide)
Once-weekly injection. Dual GIP & GLP-1 receptor agonist. Average 20.9% body weight loss in the SURMOUNT-1 phase III trial over 72 weeks.
Read the full Mounjaro guide →MHRA approved — NICE TA664
Saxenda (liraglutide)
Once-daily injection. GLP-1 receptor agonist. Average 8% body weight loss over 56 weeks alongside diet and exercise in the SCALE trial.
Read the full Saxenda guide →For a complete overview of all MHRA-approved prescription weight loss options, including a full comparison table, see our guide to weight loss medication in the UK →
Think prescription treatment could help you?
Complete a free online consultation with a GPhC-registered prescriber (pharmacy #9011198). Medication dispatched with discreet next-day delivery if eligible.
Explore Weight Loss TreatmentsFrequently Asked Questions
What are the most common causes of weight gain?
The most common causes of weight gain are a sustained calorie surplus driven by a diet high in ultra-processed foods, reduced physical activity, poor sleep (which disrupts hunger hormones), and chronic stress (which raises cortisol and promotes fat storage). Additional contributors include weight-gaining medications such as antidepressants and corticosteroids, and hormonal conditions such as hypothyroidism, PCOS, and insulin resistance. Genetic factors account for 40–70% of BMI variability and can make weight management significantly harder for some people.
What are the health risks of excess weight?
Excess weight is associated with substantially elevated risks of type 2 diabetes (up to 80 times higher), cardiovascular disease, stroke, obstructive sleep apnoea, osteoarthritis, non-alcoholic fatty liver disease, and 13 types of cancer including breast, bowel, kidney, and uterine cancers. Mental health conditions including depression and anxiety are bidirectionally associated with obesity. Even a 5–10% reduction in body weight produces clinically meaningful improvements across multiple health outcomes.
What BMI qualifies for prescription weight loss medication?
NICE guidelines recommend considering prescription weight loss medication for adults with a BMI of 30 or above, or a BMI of 27–29.9 in the presence of at least one weight-related health condition such as type 2 diabetes, hypertension, or high cholesterol. Eligibility also requires evidence that lifestyle modification alone has not produced clinically meaningful weight loss. A full medical consultation with a qualified prescriber is required before any prescription can be issued.
Can I get weight loss medication online in the UK?
Yes, through a GPhC-registered pharmacy with qualified independent prescribers. Access Doctor (GPhC #9011198) provides online consultations reviewed by pharmacist independent prescribers. If clinically eligible, a prescription is issued and medication is dispatched with next-day delivery. It is not legal or safe to obtain prescription weight loss medications without a valid prescription from a qualified UK prescriber.
How much weight can I expect to lose with prescription medication?
Results vary by treatment and individual. In the SURMOUNT-1 trial, Mounjaro (tirzepatide) 15mg produced an average body weight loss of 20.9% over 72 weeks alongside lifestyle modification. Saxenda (liraglutide) produced an average of approximately 8% weight loss over 56 weeks in the SCALE trial. All treatments produce greater results when combined with a reduced-calorie diet and increased physical activity. Individual responses vary based on adherence, metabolic factors, and baseline weight.
Is prescription weight loss medication safe?
MHRA-approved prescription weight loss medications have been assessed for safety and efficacy through rigorous clinical trials and regulatory review. Like all medicines, they carry potential side effects — the most common for Mounjaro and Saxenda being gastrointestinal (nausea, diarrhoea), particularly during dose escalation. A full clinical assessment is required before prescribing to identify any contraindications. All prescriptions through Access Doctor are reviewed by GPhC-registered pharmacist independent prescribers.
References
- NICE. Obesity: identification, assessment and management (CG189). National Institute for Health and Care Excellence, 2014 (updated 2023). nice.org.uk/guidance/cg189
- NHS Digital. Health Survey for England 2021/22. NHS England. digital.nhs.uk
- NICE. Tirzepatide for managing overweight and obesity (TA1026). National Institute for Health and Care Excellence, 2024. nice.org.uk/guidance/ta1026
- NICE. Liraglutide for managing overweight and obesity (TA664). National Institute for Health and Care Excellence, 2020. nice.org.uk/guidance/ta664
- NHS. Treatment: Obesity. NHS, 2023. nhs.uk/conditions/obesity/treatment
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Mounjaro and Saxenda are prescription-only medicines (POMs) that must only be used under medical supervision following a clinical assessment by a qualified prescriber. Do not start, stop, or change any medication without consulting a healthcare professional. Access Doctor is registered with the General Pharmaceutical Council (GPhC #9011198).


